DOCSLIB.ORG

Manual on Vitamin a De Ciency Disorders (VADD)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Manual on Vitamin a De Ciency Disorders (VADD) Building bridges for better nutrition. Sight and Life We care about the world’s most vulnerable populations and exist to help improve their nutritional status. Acting as their advocates, we guide original nutrition research, disseminate its ndings and facilitate dialog to bring about positive change. For more information please visit www.sightandlife.org Donald S. McLaren, Klaus Kraemer Sight and Life Press, Third Edition 2012 Manual on Vitamin A De ciency Disorders ( VADD) ( Disorders ciency De A Vitamin on Manual Manual on Vitamin A De ciency Disorders (VADD) Donald S. McLaren ISBN 978-3-906412-58-0 Sight and Life | P.O. Box 2116 | 4002 Basel | Switzerland Klaus Kraemer Manual on Vitamin A Deficiency Disorders (VADD) Copyright © Sight and Life 2012 Sight and Life is a not-for-profit All rights reserved. nutrition think tank of DSM. Sight and Life Press We care about the world’s most vulnerable pop- c/o Sight and Life ulations, and exist to help improve their nutri- DSM Nutritional Products Ltd tional status. Acting as their advocates, we PO Box 2116 guide original nutrition research, disseminate 4002 Basel its findings and facilitate dialog to bring about Switzerland positive change. We believe that the right mix of Phone +41 (0) 61 815 88 23 funding, knowledge, technology and policy will Fax +41 (0) 61 815 81 90 lead to better health. We work through advo- Email [email protected] cacy and leadership to address societal chang- Web www.sightandlife.org es affecting dietary quality. We act responsibly to disseminate information that reflects current Publications fromSight and Life can be obtained knowledge and evolving scientific evidence. We from the above address. Requests for permis- also aim to promote partnerships that are able sion to reproduce or translate Sight and Life to solve outstanding problems. publications should also be submitted to this address. The paper used in this book is acid-free and falls within the guidelines established to ensure per- This publication contains information derived manence and durability. from third party sources that do not neces- sarily represent the point of view of Sight and Cover design by S1 | Communication Design, Life and are the sole responsibility of the origi- Augsburg, Germany nal source. The mention of specific companies Proofreading by transparent – and trademarks does not imply that these are translation & text services, Berlin, Germany endorsed by Sight and Life. Although Sight and Typeset and print by Burger Druck, Life has used diligent care to ensure that the Waldkirch, Germany content of this publication is accurate and up to date, Sight and Life makes no representation ISBN 978-3-906412-58-0 or warranty regarding the accuracy, reliability or completeness of the content. This publica- tion does not constitute or provide scientific or medical advice and is distributed without war- ranty of any kind, either express or implied. The reader shall be solely responsible for any inter- pretation or use of the material contained here- Carbon-neutral production in. In no event shall Sight and Life be liable for any damages arising from the reader‘s reliance upon, or use of, these materials. Donald S. McLaren, Klaus Kraemer Sight and Life Press, Third Edition 2012 Manual on Vitamin A Deficiency Disorders (VADD) II Acknowledgements The Sight and Life Manual on Vitamin A We would like to take this opportunity to Deficiency Disorders (VADD) is now appearing acknowledge the support we have experienced in its 3rd edition. Although our scope has broad- during the last couple of years in preparing the ened from “sight”, a single focus on vitamin A, to 3rd edition of this book. There are many people “life”, a multiple micronutrient focus, we believe to acknowledge who have been associated with that vitamin A remains sufficiently important and this project. We would therefore like to start with interesting for us to dedicate a whole book to this apologies to those who we may have omitted nutrient. to mention. Extraordinary thanks go to Svenia Sayer-Ruehmann and Anne-Catherine Frey from This book not only draws on the latest scient- the Sight and Life team for their skilful tech- ific research and expert insights, but also benefits nical support, without which this publication greatly from the work of previous generations would have never been completed. Further, our of scientists and policy-makers. As a result, it is Sight and Life interns Laurence Curty and Sarah almost impossible to acknowledge all those who Diouf both merit special mention. We continue have contributed their expertise. Key sources in- to appreciate Yvonne Bearne for her proofread- clude, among others, journal articles, policy state- ing, and the Burger Druck team for laying out the ments, reports, fact sheets, guidelines, reference book. We also wish to thank the World Health books, websites and – of course – the data and Organization for its kind permission to reprint the research to be found in Sight and Life Magazine vitamin A deficiency world maps. Last but not itself. least, Royal DSM deserves our special apprecia- tion for its continuous support of Sight and Life; in particular, we would also like to thank Stephan Tanda, Chairman of the Sight and Life Steering Committee, for writing his encouraging foreword to this volume. III3 PrefAce This Third Edition of the Sight and Life demands of the time do not seem to permit the Manual on Vitamin A Deficiency Disorders luxury of extreme specialization. Henceforth (VADD) is likely to be the last. This is not be- source materials like this manual will also need cause there is nothing more to learn about the sub- to focus more on VMD in general. Sight and ject. It is because in recent years there has been Life sees this as a key role for itself in the future a major shift in the approach to the control of as we continue to evolve to ensure that we make a vitamin and mineral deficiencies (VMD) or multi- valuable contribution. micronutrient deficiencies (MMD) – including VADD. This is largely due to the fact that it is now The Third Edition has not surprisingly in- well recognized that VMD tend to occur together creased considerably in size and includes three rather than on their own – a tendency that is most new chapters. The first of these is specifically likely explained by the fact that most micronutri- titled ‘Foreground’ (as opposed to Background), ents are found in the same classes of foodstuffs, in order to emphasize, from the start, that the especially fruit, vegetables, fish and meat. Until focus of the Manual is on the control of VADD recently, it was general practice to identify and and that this objective should be kept in mind combat the most serious forms of deficiency, usu- throughout the book. Chapter 2 illustrates how ally of a single micronutrient. Prominent among essential and versatile the vitamin A molecules these have been vitamin A, iron, iodine, zinc and are – together with their close relatives found folate. Today, although there remains a great deal in nature, the carotenoids. Without them human to be learned about the individual roles and func- life, vision, growth and development would not tions of most micronutrients in human nutrition, be possible. The bioavailability of carotenoids interest is increasingly focused on their interrela- has become so important that it now requires its tionship, especially as micronutrient intervention own chapter (Chapter 5). In addition, the effect programs are on the increase and many are in the that the acute phase response (APR) has on serum process of being scaled-up. retinol levels is of such significance that, after an introduction to the issue in Chapter 7, it remains a The recognition of the interconnected relation- prominent feature in several subsequent chapters. ship of the micronutrients is further highlighted As so often in the field of VMD, the work on APR by the disbanding of the International Vitamin A has been pioneered in relation to VADD, but its Consultative Group (IVACG) and International effect in relation to other micronutrient deficien- Nutritional Anemia Consultative Group (INACG), cies has received little attention and much more which were set up more than thirty years ago to research is necessary. assist in the control of specific nutritional defi- ciencies. They have been replaced by the all en- This edition also includes in Chapter 12 the compassing Micronutrient Forum (MF), which latest available data on the global occurrence held its first scientific meeting in April 2007. It is of VAD from the World Health Organization no exaggeration to say that hundreds of nutrition- (WHO). Attention is drawn to the inability, over related scientists, whose knowledge and research the past several years, to determine accurate prev- efforts were virtually confined to a single micro- alence figures for the number of blind persons liv- nutrient, will now have to broaden their area of ing in any given country or region of the world or expertise and research. Rightly or wrongly, the within any vulnerable group etc., due to the deci- IV Preface sion to no longer report non-blinding xerophthal- rophthalmia) had been brought under control to a mia and blinding xerophthalmia separately. As a large extent. However, at around the same time it consequence, while data on other causes of blind- was recognized that the problem had several other ness are becoming increasingly precise, vitamin A concerning elements: deficiency blindness is included under the heading of ‘other causes of childhood blindness’
Load more

Recommended publications
  • Topical Serum for Treatment of Keratomalacia
    PROCEDURES PRO > OPHTHALMOLOGY > PEER REVIEWED Topical Serum for Treatment of Keratomalacia Amy Knollinger, DVM, DACVO Eye Care for Animals Salt Lake City, Utah Corneal Anatomy An understanding of corneal anatomy is vital to determine if serum therapy for the treatment of keratomalacia should be initiated. The cornea makes up the anterior por- tion of the globe and provides multiple functions for vision: it is transparent (despite originating from surface ectoderm), thereby allowing for clear vision; it acts as the major refractive (bending of light) surface of the globe; and it provides a protective barrier between the globe and the environment The cornea consists of 4 layers in domestic species, being approximately 0.45–0.55 mm thick in the normal dog. The corneal epithelium is the most external layer overly- What You Will Need ing the stromal layer, which accounts for 90% of the total corneal thickness. The cor- n Sterile gloves neal epithelium in the dog and cat is 5–11 cells thick and has a turnover rate of n approximately 7 days.1 The stroma is made up of collagen fibers, which are precisely Clean #40 clipper blade arranged in parallel sheets running the entire diameter of the cornea, allowing for its n Chlorhexidine scrub and solution transparency. The third layer is an acellular membrane (ie, Descemet’s membrane), n Sterile needle and syringe which forms the basement membrane for the innermost layer, the endothelium. The n corneal endothelium is a single layer of hexagonally shaped cells forming the internal Red top sterile blood collection or barrier between the anterior chamber and the cornea.2 serum separator tube n Centrifuge Corneal Disease n Sterile pipette Corneal ulcers are classified by underlying cause.
    [Show full text]
  • 4-Hydroxyphenyiretinamide
    Handbook 4 4-Hydroxyphenyiretinamide 1. Chemical and Physical Melting-point Characteristics 173-175 °C (Shealy etal., 1984; Budavari etal., 1996) 1.1. Nomenclature Solubility See General Remarks, section 1.4. Soluble in most organic solvents, fats, oils and aqueous micellar solutions; sparingly soluble in 1.2 Name water, e.g. 13 nmol/L at pH 6.5 (Li et al., 1996). Chemical Abstracts Services Registry Number 65646-68-6 Spectroscopy 1% UV and visible: ? 362 (methanol), E 1 IUPAC systematic name 1225, EM 47 900 (Budavari et al., 1996; Barua & N-[4-(all-E)-9, 13-Dimethyl-7-(1, 1,5-trimethylcy- Fun, 1998). Higher EM values, i.e. 57 100 and 56 clohex-5 -en-6-yl)nona- 7,9,11,1 3-tetraen- 15- 400, have also been reported (Formelli et al., 1996). oyl]aminophenol or N-[4-(all E)-3, 7-dimethyl-9- (2,2,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8- Nuclear magnetic resonance: tetraen-1-oyl]aminophenol 'H-NMR [(CD3)SO4, 100 MHz]: 8 1.03 (1,1-CH3), 1.3-1.8 (2-CH2, 3-CH), 1.70 (5-CH), 1.8-2.2 Synonyms (4-CH2), 1.99 (9-CH), 2.36 (13-CH), 6.03 (14-H), Fenretinide, 4-HPR, N-(4-hydroxyphenyl)reti- 6.1-6.6 (7-H, 8-H, 10-H, 12-H), 6.99 (11-H), namide, hydroxyphenyl-retinamide, N-(4-hydro- 6.6-6.8 and 7.3-7.6 (benzene ring -H), 9.15 (NH), xyphenyl)retinamide, N-(4-hydroxyphenyl)-all- 9.74 (OH) (Coburn et al., 1983; Shealy et al., tnins-retinamide 1984).
    [Show full text]
  • JMSCR Vol||08||Issue||02||Page 208-210||February 2020
    JMSCR Vol||08||Issue||02||Page 208-210||February 2020 http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v8i2.40 Keratomalacia - A Case Report Authors Deepthi Pullepu1*, Deepthi Janga2, V Murali Krishna3 *Corresponding Author Deepthi Pullepu Department of Ophthalmology, Rangaraya Medical College, Kakinada, Andhra Pradesh, India Abstract Xerophthalmia refers to an ocular condition of destructive dryness of conjunctiva and cornea caused due to severe vitamin A deficiency. Usually affects infants, children and women of reproductive age group. It is estimated to affect about one-third of children under the age of five around the world. Keratomalacia means dry and cloudy cornea which melts and perforates, caused due to severe vitamin A deficiency. Here we describe a case of 21 year old female with neurofibromatosis type 1 presenting with keratomalacia. Keywords: Vitamin A deficiency, Xerophthalmia, Keratomalacia. Introduction blindness is a significant contributor Vitamin A is essential for the functioning of the In India, it is estimated that there are immune system, healthy growth and development approximately 6.8 million people who have vision of body and is usually acquired through diet. less than 6/60 in at least one eye due to corneal Globally, 190 million children under five years of diseases; of these, about a million have bilateral age are affected by vitamin A deficiency involvement. They suffer from an increased risk of visual Corneal blindness resulting due to this disease can impairment, illness and death from childhood be completely prevented by institution of effective infections such as measles and those causing preventive or prophylactic measures at the diarrhoea community level.
    [Show full text]
  • Involvement of the Eye in Protein Malnutrition * -303
    Bull. Org. mond. Sante 1958, 19, 303-314 Bull. Wld Hith Org. INVOLVEMENT OF THE EYE IN PROTEIN MALNUTRITION * D. S. McLAREN, M.D., Ph.D., D.T.M. & H. Medical Research Officer, East African Institute for Medical Research, Mwanza, Tanganyika Formerly at the MRC Human Nutrition Research Unit, National Institute for Medical Research, London SYNOPSIS An extensive review of the literature on protein malnutrition, with special reference to the frequency of involvement of the eyes, has been made by the author. Consideration of accounts from all parts of the world and in many different languages, including early as well as more recent descriptions of the syndrome, indicates that this important complication has not received sufficient attention hitherto. The evidence available suggests that it is nearly always an accompanying deficiency of vitamin A that is responsible. Less commonly reported-and producing less severe effects-is deficiency of the B-complex vitamins, and there is no clear evidence to date that protein deficiency itself damages the eyes in these cases. The ways in which protein lack might interfere with various aspects of vitamin-A metabolism are discussed, but it is pointed out that their actual significance in human disease is not yet known. A low dietary intake of vitamin A is regarded by the author as being the prime factor in the causation of eye complications, and attention is drawn to the necessity to correct this as part of any prophylactic or therapeutic programme aimed primarily at combat- ing protein malnutrition. The syndrome known by such various names as kwashiorkor, nutritional oedema syndrome, sindrome pluricarencial, and many others (Trowell, Davies & Dean, 1954), and characterized chiefly by a dietary deficiency ofprotein, has been reported as occurring amongst most of the malnourished communities of the world.
    [Show full text]
  • Microencapsulation of Amorphous Solid Dispersions of Fenretinide Enhances Drug Solubility and Release from PLGA in Vitro and in Vivo T ⁎ Kari Nietoa, Susan R
    International Journal of Pharmaceutics 586 (2020) 119475 Contents lists available at ScienceDirect International Journal of Pharmaceutics journal homepage: www.elsevier.com/locate/ijpharm Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo T ⁎ Kari Nietoa, Susan R. Malleryb, Steven P. Schwendemana,c, a Department of Pharmaceutical Sciences and The Biointerfaces Institute, University of Michigan, Ann Arbor, MI, United States b Division of Oral Maxillofacial Pathology & Radiology, College of Dentistry, Ohio State University, Columbus, OH, United States c Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States ARTICLE INFO ABSTRACT Keywords: The purpose of this study was to develop solid dispersions of fenretinide(4HPR), incorporate them into poly Fenretinide (4HPR) (lactic-co-glycolic)(PLGA) millicylindrical implants, and evaluate the resulting implants in vitro and in vivo for polyvinylpyrrolidone (PVP) future applications in oral cancer chemoprevention. Due to the extreme hydrophobicity of 4HPR, 4HPR-poly- amorphous solid dispersion (ASD) vinylpyrrolidone (PVP) amorphous solid dispersions(ASDs) were prepared for solubility enhancement. The Solubility enhancement optimal PVP-4HPR ratio of 9/1(w/w) provided a 50-fold solubility enhancement in aqueous media, which was Poly(lactic-co-glycolic) (PLGA) sustained over 1 week. PVP-4HPR ASD particles were loaded into PLGA millicylinders and drug release was In vivo release long-acting release (LAR) evaluated in vitro in PBST and in vivo by recovery from subcutaneous injection in rats. While initial formulations of PLGA PVP-4HPR millicylinders only released 10% 4HPR in vitro after 28 days, addition of the plasticizer triethyl-o-acetyl-citrate(TEAC) into PVP-4HPR ASDs resulted in a 5.6-fold total increase in drug release.
    [Show full text]
  • Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-Like Growth Arrest in MCF-7 Breast Carcinoma Cells
    Research Article Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells Yuhong Chen,1 Milos Dokmanovic,1 Wilfred D. Stein,1,2 Robert J. Ardecky,3 and Igor B. Roninson1 1Cancer Center, Ordway Research Institute, Albany, New York; 2Institute of Life Sciences, Hebrew University, Jerusalem, Israel; and 3Ligand Pharmaceuticals, Inc., San Diego, California Abstract retinoids is most often attributed to the induction of differentia- Biological effects of retinoids are mediated via retinoic acid tion, but these compounds were also shown to stop the growth of (RA) receptors (RAR) and retinoid X receptors (RXR). The tumor cells by inducing apoptosis or accelerated senescence (1, 2). best-characterized mechanism of retinoid action is stimula- In particular, treatment of two human breast carcinoma cell lines tion of transcription from promoters containing RA response with all-trans retinoic acid (RA) or fenretinide, in vitro or in vivo, elements (RARE). Retinoids induce senescence-like growth induces a senescence-like phenotype characterized by increased h arrest in MCF-7 breast carcinoma cells; this effect is cell size and expression of senescence-associated -galactosidase h associated with the induction of several growth-inhibitory (SA- -gal; refs. 3, 4). This phenotype, as investigated in MCF-7 cells, genes. We have nowfound that these genes are induced by is associated with irreversible growth arrest and up-regulation of RAR-specific but not by RXR-specific ligands. Genome-scale several intracellular and secreted proteins with known growth- microarray analysis of gene expression was used to compare inhibitory activities.
    [Show full text]
  • Clinical Case Revista Colombiana De Ciencias Pecuarias
    Estrada RD et al Melting ulcer in a colt 31 Clinical case Revista Colombiana de Ciencias Pecuarias Melting ulcer in a colt: clinical management and evolution ¤ Úlcera fundente en un potro: manejo clínico y evolución Úlcera colagenolítica em um potro: manejo clínico e evolução Rubén D Estrada 1, MV; Susana Penagos 2, est MV; Elizabeth Viera 2, est MV; Paula A Angulo 2, est MV; Maria P Arias 2*, MV, MS, PhD. 1MV Actividad independiente 2Facultad de Medicina Veterinaria y Zootecnia, Universidad CES, AA 054591, Medellín, Colombia (Received: June 1, 2012; accepted: November 19, 2012) Summary Anamnesis : a colt showing a whitish coloration accompanied by abundant secretion on the left eye was examined. Clinical and laboratory findings: at ophthalmological examination, signs of melting ulcer were observed. Culture isolation revealed positive growing of Flavobacterium sp. and Gram-negative rods. Treatment approach : several keratectomies and tarsorrhaphies, as well as exhaustive antiproteinases, anti- inflammatory, and antibiotic treatments, were conducted. Treatment focused on reducing inflammatory response, eliminating infective organisms, and promoting epithelial healing. Colt showed complete recovery of vision after 3 months. Conclusions: clinical management of melting ulcer implies exhaustive, though unexpensive, treatment. Key words: cornea, keratectomy, keratomalacia, ophthalmology, tarsorrhaphy Resumen Anamnesis : se examinó un potro que presentó una coloración blanquecina acompañada de abundante secreción en el ojo izquierdo. Hallazgos clínicos y de laboratorio : al examen oftalmológico se observaron signos de ulcera fundente. El aislamiento por cultivo mostró crecimiento de Flavobacterium sp. y cocos Gram negativos. Abordaje terapéutico : se realizaron varias queratectomías y tarsorrafias, además de un tratamiento exhaustivo con antiproteinasas, antiinflamatorios y antibióticos enfocado a reducir la respuesta inflamatoria, eliminar los microorganismos infecciosos y promover la cicatrización epitelial.
    [Show full text]
  • Bilateral Keratomalacia Secondary to Diet Induced Vitamin a Deficiency in an Ethiopian Young Woman: a Case Report
    Bilateral Keratomalacia… Kumale T. et al. 295 CASE REPORT Bilateral Keratomalacia Secondary to Diet Induced Vitamin A Deficiency in an Ethiopian Young woman: A Case Report Kumale Tolesa Daba1*, Dagmawit Kifle1, Jafer Kedir Ababora1 ABSTRACT OPEN ACCESS BACKGROUND: Diet induced vitamin A deficiency is less Citation: Kumale Tolesa Daba, Dagmawit commonly seen in otherwise healthy adults, due to large store of Kifle, Jafer Kedir Ababora. Bilateral vitamin A in the body. Night blindness is the commonest Keratomalacia Secondary to Diet Induced Vitamin A Deficiency in an Ethiopian manifestation of vitamin A deficiency in adults, whereas Young woman: A Case Report. Ethiop J Keratomalacia is a rare manifestation. Health Sci. 2018;29(2):295 doi:http://dx.doi.org/10.4314/ ejhs. v29i2.18 CASE REPORT: A 27 years old Ethiopian woman came to Jimma Received: June 22, 2018 University Department of Ohthalmology with a compliant of Accepted: October 27, 2018 protrusion of the globe content of both eyes within a week, after Published: March 1, 2019 Copyright: © 2019 Kumale Tolosa Daba, having redness and fear of light of both eyes for 2 months. She was et al. This is an open access article a mother of twins and had low socioeconomic status. On general distributed under the terms of the Creative examination, she was cachectic with enlarged parotid glands. On Commons Attribution License, which permits unrestricted use, distribution, and ocular examination, she was bilaterally blind and had dry ocular reproduction in any medium, provided the surface. There was bilaterally melted cornea with prolapsed uveal original author and source are credited.
    [Show full text]
  • The Mechanisms of Fenretinide-Mediated Anti-Cancer Activity and Prevention of Obesity and Type-2 Diabetes
    *Manuscript Click here to view linked References The mechanisms of Fenretinide-mediated anti-cancer activity and 1 2 3 prevention of obesity and type-2 diabetes. 4 5 Authors: Nimesh Mody* and George D. Mcilroy. 6 7 8 Institute of Medical Sciences, College of Life Sciences & Medicine, University of Aberdeen, 9 10 Aberdeen, UK 11 12 * corresponding author 13 14 15 Running title: The synthetic retinoid, Fenretinide. 16 17 Abbreviations: Fenretinide, FEN; 18 19 20 Keywords: apoptosis, autophagy, reactive oxygen species, retinoic acid, adipogenesis, 21 22 obesity, type-2 diabetes. 23 24 25 Word count: 7169 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 1 63 64 65 ABSTRACT 1 2 3 4 Fenretinide remains the most investigated retinoid compound for the prevention of cancer. Its 5 6 clinical use remains a genuine possibility due to a favourable toxicological profile and 7 8 accumulation in fatty tissues. Like other well-characterised pharmacological therapies, 9 10 11 Fenretinide has been shown to affect multiple signalling pathways. Recent findings have 12 13 discovered additional beneficial properties the synthetic retinoid was not intentionally 14 15 16 designed for, including the prevention of high-fat diet-induced obesity and insulin resistance. 17 18 These preclinical findings in rodents are timely since obesity has reached pandemic 19 20 21 proportions and safe effective therapeutics are severely lacking. Recent investigations have 22 23 proposed various mechanisms of action for the beneficial effects of Fenretinide.
    [Show full text]
  • A Group of Chimeric Antigen Receptors (Cars)
    (19) *EP003632461A1* (11) EP 3 632 461 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2020 Bulletin 2020/15 A61K 39/00 (2006.01) (21) Application number: 18198850.2 (22) Date of filing: 05.10.2018 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • SALZER, Benjamin GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 3744 Stockern (AT) PL PT RO RS SE SI SK SM TR •LEHNER, Manfred Designated Extension States: 1090 Vienna (AT) BA ME • TRAXLMAYR, Michael Designated Validation States: 1180 Vienna (AT) KH MA MD TN (74) Representative: Sonn & Partner Patentanwälte (71) Applicants: Riemergasse 14 • St. Anna Kinderkrebsforschung 1010 Wien (AT) 1090 Vienna (AT) • Universität für Bodenkultur Wien 1180 Wien (AT) (54) A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) (57) Disclosed is a group of chimeric antigen recep- regulating molecule and optionally reduced by another tors (CARs) consisting of two, three or four CAR mole- regulating molecule, or occurs in the absence of a regu- cules, lating molecule and is reduced by a regulating molecule, wherein the members of the group of CARs can be dif- and ferent or identical in their amino acid sequences to one wherein the ectodomain of each CAR molecule of the another, and group in its prevalent conformation is free of cysteine wherein each of the CAR molecules of the group com- amino acid moieties which are able to form intermolecular prise at least a transmembrane domain and an ectodo- disulphide bonds with other CAR molecules of the
    [Show full text]
  • The Effects of N-3 Fatty Acids and Bexarotene on Breast Cancer Cell Progression
    Journal of Cancer Therapy, 2011, 2, 710-714 doi:10.4236/jct.2011.25096 Published Online December 2011 (http://www.SciRP.org/journal/jct) The Effects of n-3 Fatty Acids and Bexarotene on Breast Cancer Cell Progression Jessica Trappmann, Susan N. Hawk Department of Nutrition, Exercise and Health Sciences, Central Washington University, Ellensburg, USA. E-mail: [email protected] Received September 28th, 2011; revised October 25th, 2011; accepted November 7th, 2011. ABSTRACT Breast cancer cell growth can be inhibited in vivo by retinoid X receptor (RXR) specific retinoids. In both animal and cell culture studies, omega-3 fatty acids share growth regulatory effects similar to those of RXR specific retinoids (rex- inoids). One synthetic rexinoid, bexarotene (LCD 1069, Targretin), is used clinically to treat cancer patients. Of con- cern is that some patients are unable to tolerate high doses of such treatment drugs. We hypothesized that n-3 fatty ac- ids and bexarotene may work synergistically to slow breast cancer cell growth. To test our hypothesis, we used MCF-7 human mammary carcinoma cells and an in vitro cell culture model. We investigated the relationship between the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) alone and in conjunction with bex- arotene in slowing MCF-7 cell growth. Following a 72 hr incubation with the respective treatments, bexarotene en- hanced cell growth (p < 0.05) while DHA showed a strong growth inhibitory effect which was not enhanced by the ad- dition of bexarotene (p < 0.05). EPA alone was not effective in altering cell growth (p < 0.05).
    [Show full text]
  • Therapy-Resistant Dry Itchy Eyes Rima Wardeh* , Volker Besgen and Walter Sekundo
    Wardeh et al. Journal of Ophthalmic Inflammation and Infection (2019) 9:13 Journal of Ophthalmic https://doi.org/10.1186/s12348-019-0178-7 Inflammation and Infection BRIEFREPORT Open Access Therapy-resistant dry itchy eyes Rima Wardeh* , Volker Besgen and Walter Sekundo Abstract An 8 years old male presented to our clinic with dry eye symptomes. Different therapiy attemps were made in the last few months and did not lead to any improvement. Examining this patient revealed multiple signs of vitamin A deficiency, which could confirmed by laboratory examination. The initial substitution of vitamin A led to a fast rehabilitation and a following nutrition consulting kept the patient symptom-free over 6 month follow up. Vitamin A deficiency -although rare in the developed countries- is an importent differential diagnosis of the dry eye especially in children. Vitamin A deficiency not only causes ocular manifistaion, but also general symptoms. Dietary change and initial subtitution is the key element for a fast and sustaining improvement. Medical history follow-up examination showed no improvement in the An 8-year-old male child was referred to our pediatric visual acuity nor in the corneal surface. In addition, the ophthalmology department because of burning sensation conjunctiva had developed triangular-shaped superficial and itching in both eyes during the last 4 months. His spots with keratinization in the bulbar conjunctiva nas- mother reported that the child was always pinching his ally, inferiorly, and temporally near the limbus of both eyes while reading or focusing. Topical therapy with eyes. With these findings, the diagnosis of conjunctival dexamethasone eye drops, antihistamine eye drops and corneal xerosis due to vitamin A deficiency was sus- (ketotifen), antibiotic eye drops (ofloxacine) and im- pected.
    [Show full text]